Literature DB >> 11218920

Pathogenesis of hepatocellular carcinoma.

G A Macdonald1.   

Abstract

The pathogenesis of HCC is poorly understood at present. There is insufficient understanding to propose a robust general model of hepatic carcinogenesis, partly because pathogenic host and environmental factors show significant regional variation, making such generalization difficult. Figure 4 is a model based on data presented in this article. Multiple risk factors for HCC have been identified, including cirrhosis, male gender, increasing patient age, toxins, chronic viral hepatitis, and other specific liver diseases. The understanding of how the individual risk factors result in genetic changes is rudimentary, and there is even less understanding about interactions between risk factors. Future studies should acknowledge the geographic origin of the HCCs studied and consider the effects of cirrhosis, gender, and age. A more rigorous approach to these factors may help explicate the interaction with specific liver diseases so that a comprehensive model of hepatic carcinogenesis can be developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11218920     DOI: 10.1016/s1089-3261(05)70154-9

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

1.  Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.

Authors:  Ming-De Huang; Xiao-Fei Chen; Gang Xu; Qing-Quan Wu; Jian-Huai Zhang; Guo-Feng Chen; Yong Cai; Fu-Zhen Qi
Journal:  DNA Cell Biol       Date:  2011-11-09       Impact factor: 3.311

2.  Altered aquaporin 9 expression and localization in human hepatocellular carcinoma.

Authors:  Srikanth Padma; Alan M Smeltz; Peter M Banks; David A Iannitti; Iain H McKillop
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

3.  Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.

Authors:  Dairmuid M Moran; M Adrian Mattocks; Paul A Cahill; Leonidas G Koniaris; Iain H McKillop
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

Review 4.  Screening for hepatocellular carcinoma: why, when, how?

Authors:  Miguel R Arguedas
Journal:  Curr Gastroenterol Rep       Date:  2003-02

5.  Corn peptides protect against thioacetamide-induced hepatic fibrosis in rats.

Authors:  Jie Lv; Zhi-Kui Nie; Jiu-Liang Zhang; Feng-Yan Liu; Zhen-Zhen Wang; Zhi-Li Ma; Hui He
Journal:  J Med Food       Date:  2013-09-24       Impact factor: 2.786

6.  The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancer.

Authors:  Wojciech Jelski; Bogdan Zalewski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2008-01-26       Impact factor: 3.199

7.  The establishment and characterization of the first canine hepatocellular carcinoma cell line, which resembles human oncogenic expression patterns.

Authors:  Sacha Y Boomkens; Bart Spee; Jooske Ijzer; Ronald Kisjes; Herman F Egberink; Ted Sgam van den Ingh; Jan Rothuizen; Louis C Penning
Journal:  Comp Hepatol       Date:  2004-11-26

8.  Size of canine hepatocellular carcinoma as an adverse prognostic factor for surgery.

Authors:  Yury Vatnikov; Ilya Vilkovysky; Evgeny Kulikov; Irina Popova; Nadia Khairova; Aleksey Gazin; Andrey Zharov; Darya Lukina
Journal:  J Adv Vet Anim Res       Date:  2020-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.